These anti-tumor effects of GEN were identified in both in vitro and in clinical cases of a wide variety of cancer types, including prostate cancer, breast cancer, colon cancer, gastric cancer, lung cancer, pancreatic cancer, and lymphoma5–8. This evidence concerns the gene GEN1 and lung carcinoma.